These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1766 related articles for article (PubMed ID: 34350813)

  • 21. SARS-CoV-2 antibody prevalence among healthcare workers: A cross-sectional study at a quaternary healthcare center in Saudi Arabia.
    Amer HA; Abdallah HA; Alkheledan HS; Alzarzour SH; Shrahily A; Tamim H; Alqahtani SA; Memish ZA
    J Infect Public Health; 2022 Mar; 15(3):343-348. PubMed ID: 35167996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroprevalence of anti-SARS-CoV-2 IgG among healthcare workers of a large university hospital in Milan, Lombardy, Italy: a cross-sectional study.
    Lombardi A; Mangioni D; Consonni D; Cariani L; Bono P; Cantù AP; Tiso B; Carugno M; Muscatello A; Lunghi G; Pesatori AC; Riboldi L; Ceriotti F; Bandera A; Gori A
    BMJ Open; 2021 Feb; 11(2):e047216. PubMed ID: 33619203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Half-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodies and Rule Compliance in German Hospital Employees.
    Herzberg J; Vollmer T; Fischer B; Becher H; Becker AK; Sahly H; Honarpisheh H; Guraya SY; Strate T; Knabbe C
    Int J Environ Res Public Health; 2021 Oct; 18(20):. PubMed ID: 34682719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area.
    Alroqi F; Masuadi E; Alabdan L; Nogoud M; Aljedaie M; Abu-Jaffal AS; Barhoumi T; Almasoud A; Alharbi NK; Alsaedi A; Khan M; Arabi YM; Nasr A
    J Infect Public Health; 2021 Sep; 14(9):1268-1273. PubMed ID: 34479078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.
    Iruretagoyena M; Vial MR; Spencer-Sandino M; Gaete P; Peters A; Delgado I; Perez I; Calderon C; Porte L; Legarraga P; Anderson A; Aguilera X; Vial P; Weitzel T; Munita JM
    BMC Infect Dis; 2021 May; 21(1):478. PubMed ID: 34039287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 seroprevalence in health care workers from 10 hospitals in Quebec, Canada: a cross-sectional study.
    Brousseau N; Morin L; Ouakki M; Savard P; Quach C; Longtin Y; Cheng MP; Carignan A; Dufresne SF; Leduc JM; Lavallée C; Gauthier N; Bestman-Smith J; Arrieta MJ; Ishak M; Lévesque S; Martin P; De Serres G
    CMAJ; 2021 Dec; 193(49):E1868-E1877. PubMed ID: 34903591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study.
    Alasmari F; Mukahal M; Alqurashi AA; Huq M; Alabdrabalnabi F; AlJurayyan A; Alkahtani SM; Assari FS; Bashaweeh R; Salam R; Aldera S; Alkinani OM; Almutairi T; AlEnizi K; Tleyjeh I
    PLoS One; 2022; 17(8):e0272818. PubMed ID: 35960736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4
    Marklund E; Leach S; Nyström K; Lundgren A; Liljeqvist JÅ; Nilsson S; Yilmaz A; Andersson LM; Bemark M; Gisslén M
    Front Immunol; 2021; 12():750448. PubMed ID: 34795668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.
    Meylan S; Dafni U; Lamoth F; Tsourti Z; Lobritz MA; Regina J; Bressin P; Senn L; Grandbastien B; Andre C; Fenwick C; D'Acremont V; Croxatto A; Guilleret I; Greub G; Manuel O; Calandra T; Pantaleo G; Lazor-Blanchet C;
    BMJ Open; 2021 Jul; 11(7):e049232. PubMed ID: 34226231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.
    Musa S; Abdel Alem S; Amer K; Elnagdy T; Hassan WA; Ali MA; Gaber Y; Badary HA; Tantawi O; Abdelmoniem R; Radwan A; Yousof H; Shawky S; Talaat H; Fouad R; Kassem AM
    J Infect Public Health; 2021 Oct; 14(10):1466-1473. PubMed ID: 34175238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in Turkey].
    Özdemir A; Demir Çuha M; Telli Dizman G; Alp A; Metan G; Şener B
    Mikrobiyol Bul; 2021 Apr; 55(2):223-232. PubMed ID: 33882653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for SARS-CoV-2 seropositivity in a health care worker population during the early pandemic.
    Schubl SD; Figueroa C; Palma AM; de Assis RR; Jain A; Nakajima R; Jasinskas A; Brabender D; Hosseinian S; Naaseh A; Hernandez Dominguez O; Runge A; Skochko S; Chinn J; Kelsey AJ; Lai KT; Zhao W; Horvath P; Tifrea D; Grigorian A; Gonzales A; Adelsohn S; Zaldivar F; Edwards R; Amin AN; Stamos MJ; Barie PS; Felgner PL; Khan S
    BMC Infect Dis; 2023 May; 23(1):330. PubMed ID: 37194021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 Seroprevalence among the Health Care Staff of an Ophthalmological Reference Centre, a Cross Sectional Study.
    Magaña-Guerrero FS; Trujillo DH; Buentello-Volante B; Aguayo-Flores JE; Melgoza-González EA; Hernández J; Jiménez-Martínez MC; Pérez-Tapia SM; Garfias Y
    Ophthalmic Epidemiol; 2022 Oct; 29(5):483-490. PubMed ID: 34530684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low seropositivity for SARS-CoV-2 antibodies among healthcare workers after the first COVID-19 pandemic wave in Greece.
    Galanis P; Kaitelidou D; Prezerakos P; Kotsiopoulos I; Siskou O; Konstantakopoulou O; Hadjichristodoulou C; Tsiodras S
    Public Health; 2021 Sep; 198():223-229. PubMed ID: 34482100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Health Care Workers.
    Santosh CS; Tukaram DP; Maharudra K; Balkrishna A; Chinmay G; Aniket I; Kinge K; Nilam J
    J Assoc Physicians India; 2021 Aug; 69(8):11-12. PubMed ID: 34472805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of SARS-CoV-2 in healthcare workers from outpatient facilities and retirement or nursing homes in a Swiss canton.
    Zürcher K; Mugglin C; Suter-Riniker F; Keller PM; Egger M; Müller S; Fluri M; Hoffmann M; Fenner L
    Swiss Med Wkly; 2021 Aug; 151():w30021. PubMed ID: 34495604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Seroprevalence of SARS-CoV-2 among Healthcare Workers in a North Italy Hospital.
    Airoldi C; Patrucco F; Milano F; Alessi D; Sarro A; Rossi MA; Cena T; Borrè S; Faggiano F
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33804893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Work at inpatient care units is associated with an increased risk of SARS-CoV-2 infection; a cross-sectional study of 8679 healthcare workers in Sweden.
    Lidström AK; Sund F; Albinsson B; Lindbäck J; Westman G
    Ups J Med Sci; 2020 Nov; 125(4):305-310. PubMed ID: 32684119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence, infection, and personal protective equipment use among Colombian healthcare workers during the COVID-19 pandemic.
    Beltrán EO; Martignon S; Coronel-Ruiz C; Velandia-Romero ML; Romero-Sanchez C; Avila V; Castellanos JE
    Front Public Health; 2023; 11():1225037. PubMed ID: 37900032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain.
    Peremiquel-Trillas P; Saura-Lázaro A; Benavente-Moreno Y; Casabonne D; Loureiro E; Cabrera S; Duran A; Garrote L; Brao I; Trelis J; Galán M; Soler F; Julià J; Cortasa D; Domínguez MÁ; Albasanz-Puig A; Gudiol C; Ramírez-Tarruella D; Muniesa J; Rivas JP; Muñoz-Montplet C; Sedano A; Plans À; Calvo-Cerrada B; Calle C; Clopés A; Carnicer-Pont D; Alemany L; Fernández E
    BMJ Open; 2022 Apr; 12(4):e056637. PubMed ID: 35450905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 89.